Recent studies have suggested that secretin, like glucose, stimulates a rapid insulin response from a small storage pool. In order to evaluate the mechanism of the secretin-stimulated insulin response, small (15 U) rapidly administered intravenous injections (pulses) of secretin were given before, during, and after a 20 hr 300 mg/min glucose infusion. Contrary to previous studies demonstrating that the acute insulin response to a small (5 g) pulse of glucose given 45 min after the start of the glucose infusion was significantly diminished compared to the response to the preinfusion pulse, the acute insulin response (2-5 min Δimmuno-reactive insulin μU/ml) to 15-U secretin pulses exhibited a greater than twofold increase (before: 31.1±15.4; during: 71.2±40.4, μU/ml, mean ±SD, P < 0.02). The increased response to secretin was also found after 20 hr of continuous glucose infusion, but was not observed 1 hr after cessation of the infusion when plasma glucose levels returned to control values. Thus, this increased response to secretin was glucose dependent.
Roger L. Lerner, Daniel Porte Jr.
Title and authors | Publication | Year |
---|---|---|
Daniel Porte Jr., 13 August 1931-13 May 2023.
Kahn SE, Woods SC, Halter JB, Taborsky GJ, Schwartz MW |
Diabetes | 2024 |
Central nervous system regulation of organismal energy and glucose homeostasis
MG Myers, AH Affinati, N Richardson, MW Schwartz |
2021 | |
Pleiotropic Effects of Secretin: A Potential Drug Candidate in the Treatment of Obesity?
S Laurila, E Rebelos, MJ Honka, P Nuutila |
Frontiers in Endocrinology | 2021 |
Metabolic effects of secretin
R Sekar, BK Chow |
General and Comparative Endocrinology | 2012 |
Central and Peripheral Administration of Secretin Inhibits Food Intake in Mice through the Activation of the Melanocortin System
CY Cheng, JY Chu, BK Chow |
Neuropsychopharmacology | 2010 |
Secretin: Should we revisit its metabolic outcomes?
DH St-Pierre, F Broglio |
Journal of Endocrinological Investigation | 2010 |
International Textbook of Diabetes Mellitus
RA DeFronzo, L Mandarino, E Ferrannini |
International Textbook of Diabetes Mellitus | 2003 |
Defective insulin secretion in niddm: Integral part of a multiplier hypothesis
RP Robertson |
Journal of Cellular Biochemistry | 1992 |
Clinical aspects of islet B-cell function in non-insulin-dependent diabetes mellitus
WK Ward, JC Beard, D Porte |
Diabetes / Metabolism Reviews | 1986 |
Secretin and its C-terminal hexapeptide potentiates insulin release in mouse islets
H Kofod, B Hansen, A Lernmark, CJ Hedeskov |
American journal of physiology. Endocrinology and metabolism | 1986 |
Effects of endogenous and exogenous secretin on plasma pancreatic polypeptide concentrations in dogs
F Koizumi, A Ohkawa, T Kawamura, A Ishimori, I Sasaki, J Kameyama |
Diabetologia | 1986 |
Comparison of Type I and Type II Diabetes
M Vranic, CH Hollenberg, G Steiner |
1985 | |
Insulinotropic and gastrin-releasing action of gastrin-releasing peptide (GRP)
GH Greeley, JC Thompson |
Regulatory Peptides | 1984 |
Diagnosis and Management of Endocrine-related Tumors
RJ Santen, A Manni |
1984 | |
Effects of amino acids and gastric inhibitory polypeptide on insulin release in dogs
JG Yovos, TM O'Dorisio, TN Pappas, S Cataland, FB Thomas, H Mekhjian, LC Carey |
American journal of physiology. Endocrinology and metabolism | 1982 |
Insulin secretion in diabetes mellitus
MA Pfeifer, JB Halter, D Porte |
The American Journal of Medicine | 1981 |
Endogenous hyperglycemia restores insulin release impaired by somatostatin analogue
GJ Taborsky, D Porte |
American journal of physiology. Endocrinology and metabolism | 1981 |
Proportional inhibition of glucose-induced insulin release by somatostatin
GJ Taborsky, PH Smith |
Metabolism | 1980 |
Effects of cholecystokinin, secretin, and pancreatic polypeptide on secretion of gastric inhibitory polypeptide, insulin, and glucagon
RH Williams, J Champagne |
Life Sciences | 1979 |
Early insulin and glucagon response to subsequent pulses of arginine, glucose, and tolbutamide in normal man
AV Greco, R Manna, G Ghirlanda, L Altomonte, AG Rebuzzi, A Bertoli |
American journal of physiology. Endocrinology and metabolism | 1979 |
Release of Gastric Inhibitory Polypeptide (GIP) by Intraduodenal Acidification in Rats and Humans and Abolishment of the Incretin Effect of Acid by GIP-Antiserum in Rats
R Ebert, K Illmer, W Creutzfeldt |
Gastroenterology | 1979 |
Lack of gastrointestinal enhancement of the insulin response to glucose in newborn infants
KC King, R Schwartz, K Yamaguchi, PA Adam |
The Journal of Pediatrics | 1977 |
Pankreas
K Beck, V Becker, SW Bender, B Cremer, H Fritz, H Goebell, KH Grözinger, C Guien, B Hadorn, W Hess, J Hotz, D Kaiser, H Kasper, F Kümmerle, F Largiadèr, P Lehnert, V Lenner, W Londong, M Nagel, M Otte, H Payan, W Rick, U Ritter, O Roder, P Röttger, E Rossi, J Sahel, H Sarles, JC Sarles, J Schier, G Seifert, H Sommer, H Stahlheber, U Stephan, H Teufel, M Wanke, S Witte, KG Wormsley, MM Forell |
1976 | |
Stimulation of Secretion of Gastric Inhibitory Polypeptide and Insulin by Intraduodenal Amino Acid Perfusion
FB Thomas, EL Mazzaferri, SE Crockett, HS Mekhjian, HD Gruemer, S Cataland |
Gastroenterology | 1976 |
Somatostatin blockade of acute and chronic stimuli of the endocrine pancreas and the consequences of this blockade on glucose homeostasis
EW Chideckel, J Palmer, DJ Koerker, J Ensinck, MB Davidson, CJ Goodner |
Journal of Clinical Investigation | 1975 |
The metabolic consequences of adrenergic blockade: A review
JL Day |
Metabolism | 1975 |
Candidate Hormones of the Gut
MI Grossman |
Gastroenterology | 1974 |
The Effect of the β-Receptor Blockade (Propranolol) on the Endocrine and Exocrine Pancreatic Function in Man after the Administration of Intestinal Hormones (Secretin and Cholecystokinin-Pancreozymin)
S Raptis, H Dollinger, M Chrissiku, G Rothenbuchner, EF Pfeiffer |
European Journal of Clinical Investigation | 1973 |
Perifusion of saurian pancreatic islets and biphasic insulin release following glucose stimulation
WB Rhoten |
Comparative Biochemistry and Physiology Part A: Physiology | 1973 |